Industrial Materials
Compare Stocks
2 / 10Stock Comparison
CRMLW vs LIN
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
CRMLW vs LIN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Industrial Materials | Chemicals - Specialty |
| Market Cap | $437M | $228.85B |
| Revenue (TTM) | — | $34.66B |
| Net Income (TTM) | $-147M | $7.13B |
| Gross Margin | — | 46.0% |
| Operating Margin | — | 28.8% |
| Forward P/E | — | 27.7x |
| Total Debt | $19M | $26.99B |
| Cash & Equiv. | $1M | $5.06B |
CRMLW vs LIN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Feb 24 | May 26 | Return |
|---|---|---|---|
| Critical Metals Cor… (CRMLW) | 100 | 5454.5 | +5354.5% |
| Linde plc (LIN) | 100 | 110.0 | +10.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CRMLW vs LIN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CRMLW is the clearest fit if your priority is long-term compounding.
- 42.3% 10Y total return vs LIN's 375.2%
- +23.5% vs LIN's +11.2%
LIN carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 6 yrs, beta 0.24, yield 1.2%
- Rev growth 3.0%, EPS growth 7.1%, 3Y rev CAGR 0.6%
- Lower volatility, beta 0.24, Low D/E 67.9%, current ratio 0.88x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Quality / Margins | 20.6% margin vs CRMLW's -61.8% | |
| Stability / Safety | Beta 0.24 vs CRMLW's 2.96 | |
| Dividends | 1.2% yield; 6-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +23.5% vs LIN's +11.2% | |
| Efficiency (ROA) | 8.3% ROA vs CRMLW's -312.7%, ROIC 11.3% vs -14.6% |
CRMLW vs LIN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CRMLW vs LIN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Insufficient data to determine a leader in this category.
Income & Cash Flow (Last 12 Months)
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | — | $34.7B |
| EBITDAEarnings before interest/tax | — | $12.1B |
| Net IncomeAfter-tax profit | — | $7.1B |
| Free Cash FlowCash after capex | — | $5.1B |
| Gross MarginGross profit ÷ Revenue | — | +46.0% |
| Operating MarginEBIT ÷ Revenue | — | +28.8% |
| Net MarginNet income ÷ Revenue | — | +20.6% |
| FCF MarginFCF ÷ Revenue | — | +14.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +8.2% |
| EPS Growth (YoY)Latest quarter vs prior year | — | +13.4% |
Valuation Metrics
CRMLW leads this category, winning 1 of 1 comparable metric.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $437M | $228.8B |
| Enterprise ValueMkt cap + debt − cash | $455M | $250.8B |
| Trailing P/EPrice ÷ TTM EPS | -2.97x | 33.85x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 27.67x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.33x |
| EV / EBITDAEnterprise value multiple | — | 19.75x |
| Price / SalesMarket cap ÷ Revenue | — | 6.73x |
| Price / BookPrice ÷ Book value/share | — | 5.82x |
| Price / FCFMarket cap ÷ FCF | — | 44.97x |
Profitability & Efficiency
LIN leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
LIN delivers a 17.8% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $-23 for CRMLW. On the Piotroski fundamental quality scale (0–9), LIN scores 6/9 vs CRMLW's 1/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -23.3% | +17.8% |
| ROA (TTM)Return on assets | -3.1% | +8.3% |
| ROICReturn on invested capital | -14.6% | +11.3% |
| ROCEReturn on capital employed | -21.7% | +13.0% |
| Piotroski ScoreFundamental quality 0–9 | 1 | 6 |
| Debt / EquityFinancial leverage | — | 0.68x |
| Net DebtTotal debt minus cash | $18M | $21.9B |
| Cash & Equiv.Liquid assets | $1M | $5.1B |
| Total DebtShort + long-term debt | $19M | $27.0B |
| Interest CoverageEBIT ÷ Interest expense | -0.08x | 34.52x |
Total Returns (Dividends Reinvested)
CRMLW leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CRMLW five years ago would be worth $432,693 today (with dividends reinvested), compared to $17,394 for LIN. Over the past 12 months, CRMLW leads with a +2353.4% total return vs LIN's +11.2%. The 3-year compound annual growth rate (CAGR) favors CRMLW at 2.5% vs LIN's 11.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +97.8% | +15.5% |
| 1-Year ReturnPast 12 months | +2353.4% | +11.2% |
| 3-Year ReturnCumulative with dividends | +4226.9% | +39.7% |
| 5-Year ReturnCumulative with dividends | +4226.9% | +73.9% |
| 10-Year ReturnCumulative with dividends | +4226.9% | +375.2% |
| CAGR (3Y)Annualised 3-year return | +2.5% | +11.8% |
Risk & Volatility
LIN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
LIN is the less volatile stock with a 0.24 beta — it tends to amplify market swings less than CRMLW's 2.96 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LIN currently trades 94.7% from its 52-week high vs CRMLW's 26.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.96x | 0.24x |
| 52-Week HighHighest price in past year | $20.73 | $521.28 |
| 52-Week LowLowest price in past year | $0.17 | $387.78 |
| % of 52W HighCurrent price vs 52-week peak | +26.0% | +94.7% |
| RSI (14)Momentum oscillator 0–100 | 56.6 | 51.7 |
| Avg Volume (50D)Average daily shares traded | 47K | 2.3M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
LIN is the only dividend payer here at 1.21% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $539.71 |
| # AnalystsCovering analysts | — | 28 |
| Dividend YieldAnnual dividend ÷ price | — | +1.2% |
| Dividend StreakConsecutive years of raises | — | 6 |
| Dividend / ShareAnnual DPS | — | $6.00 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.0% |
CRMLW leads in 2 of 6 categories (Valuation Metrics, Total Returns). LIN leads in 2 (Profitability & Efficiency, Risk & Volatility).
CRMLW vs LIN: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is CRMLW or LIN a better buy right now?
Linde plc (LIN) offers the better valuation at 33.
8x trailing P/E (27. 7x forward), making it the more compelling value choice. Analysts rate Linde plc (LIN) a "Buy" — based on 28 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — CRMLW or LIN?
Over the past 5 years, Critical Metals Corp.
(CRMLW) delivered a total return of +42. 3%, compared to +73. 9% for Linde plc (LIN). Over 10 years, the gap is even starker: CRMLW returned +42. 3% versus LIN's +375. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — CRMLW or LIN?
By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.
24β versus Critical Metals Corp. 's 2. 96β — meaning CRMLW is approximately 1132% more volatile than LIN relative to the S&P 500.
04Which is growing faster — CRMLW or LIN?
On earnings-per-share growth, the picture is similar: Linde plc grew EPS 7.
1% year-over-year, compared to -154. 6% for Critical Metals Corp.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — CRMLW or LIN?
Linde plc (LIN) is the more profitable company, earning 20.
3% net margin versus 0. 0% for Critical Metals Corp. — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus 0. 0% for CRMLW. At the gross margin level — before operating expenses — LIN leads at 43. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — CRMLW or LIN?
In this comparison, LIN (1.
2% yield) pays a dividend. CRMLW does not pay a meaningful dividend and should not be held primarily for income.
07Is CRMLW or LIN better for a retirement portfolio?
For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
24), 1. 2% yield, +375. 2% 10Y return). Critical Metals Corp. (CRMLW) carries a higher beta of 2. 96 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LIN: +375. 2%, CRMLW: +42. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between CRMLW and LIN?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
LIN pays a dividend while CRMLW does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.